Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Capstone Therapeutics Corp. (CAPS : NSDQ)

• Company Description    Capstone Holding Corp. primary business activities presently include the operations of TotalStone LLC, a construction materials company. Capstone Holding Corp. is headquartered in Alsip, Illinois. Number of Employees: 96

• Price / Volume Information    Yesterday's Closing Price: $0.37 Daily Weekly Monthly 20 Day Moving Average: 6,838,141 shares Shares Outstanding: 12.63 (millions) Market Capitalization: $4.71 (millions) Beta: -1.52 52 Week High: $2.07 52 Week Low: $0.26 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -10.23% -14.61% 12 Week -44.32% -48.53% Year To Date -48.74% -58.15%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 18400 76th Avenue - Tinley Park,IL 60477 USA ph: 708-371-0660 fax: 602-286-5300 investors@capstoneholdingcorp.com https://capstoneholdingcorp.com

• General Corporate Information    Officers Matthew E. Lipman - Chief Executive Officer Michael Toporek - Chairman Edward Schultz - Chief Financial Officer Charles Dana - Director Gordon Strout - Director Peer Information Capstone Therapeutics Corp. (CSRLY) Capstone Therapeutics Corp. (ARRD) Capstone Therapeutics Corp. (CGMCQ) Capstone Therapeutics Corp. (CMCJY) Capstone Therapeutics Corp. (OMRP) Capstone Therapeutics Corp. (ABLT) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: BLDG&CONST-MISC Sector: Construction CUSIP: 14068E208 SIC: 5030 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/21/26 Share - Related Items Shares Outstanding: 12.63 Most Recent Split Date: 9.00 (0.00:1) Beta: -1.52 Market Capitalization: $4.71 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/21/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.42 Price/Cash Flow: - Price / Sales: 0.09 EPS Growth vs. Year Ago Period: 55.32% vs. Previous Quarter: 92.16% Sales Growth vs. Year Ago Period: 59.97% vs. Previous Quarter: -0.99% ROE 03/31/26 - -114.15 12/31/25 - -93.49 09/30/25 - -29.50 ROA 03/31/26 - -39.74 12/31/25 - -39.69 09/30/25 - -10.60 Current Ratio 03/31/26 - 0.95 12/31/25 - 1.00 09/30/25 - 0.95 Quick Ratio 03/31/26 - - 12/31/25 - 0.26 09/30/25 - 0.35 Operating Margin 03/31/26 - -41.26 12/31/25 - -45.01 09/30/25 - -12.43 Net Margin 03/31/26 - -41.26 12/31/25 - -45.01 09/30/25 - -12.40 Pre-Tax Margin 03/31/26 - -27.43 12/31/25 - -29.98 09/30/25 - -11.46 Book Value 03/31/26 - 0.89 12/31/25 - 1.37 09/30/25 - 3.45 Inventory Turnover 03/31/26 - 2.76 12/31/25 - 2.97 09/30/25 - 3.39 Debt-to-Equity 03/31/26 - 0.79 12/31/25 - 0.75 09/30/25 - 0.29 Debt-to-Capital 03/31/26 - 49.06 12/31/25 - 47.62 09/30/25 - 21.02

Powered by Zacks Investment Research ©